TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

Benzinga Logo Benzinga By Prnewswire
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by uniQure N.V. after the company disclosed uncertainties about FDA approval for its AMT-130 drug, causing a significant stock price drop.

Insights
BMLpG   neutral

Mentioned as one of the sales agents and forward purchasers, playing a standard financial intermediary role


QURE   negative

Stock dropped over 57% after announcing potential issues with FDA approval process for AMT-130, suggesting significant regulatory and developmental challenges